Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Gastro-Intestinal Disorder: early-phase trial registry

2 of 8 indexed Gastro-Intestinal Disorder trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Gastro-Intestinal Disorder: 8 US clinical trials tracked, 2 recruiting.

Gastro-Intestinal Disorder is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Arizona State University, running 2 of these trials.

Enrollment posture brief

Registry condition gastro-intestinal-disorder

OPEN 2 | RECR 25% | LATE 0 | EARLY 5 | RANK #2176 | SPON 2

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Gastro-Intestinal Disord (th…25%
Open-enrollment share among volume-matched conditions near Gastro-Intestinal Disorder

Gastro-Intestinal Disorder lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gastro-Intestinal Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gastro-Intestinal Disorder is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Gastro-Intestinal Disorder research.

    Arizona State University accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Most Gastro-Intestinal Disorder trials plan to enrol fewer than 100 people.

    Median target enrolment is 60 among the 8 trials that report a genuine target (sentinel values excluded). 5 of those (62.5%) plan for fewer than 100 participants.

  4. Gastro-Intestinal Disorder research is mostly interventional.

    6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 23

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 3

Named interventions

Most-linked intervention names on Gastro-Intestinal Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fuji Flim Processor VP-7000, Light Source BL-7000 Device
1 trials
FMT versus placebo Biological
1 trials
Tissue Sample Collection Diagnostic test
1 trials
Urine Collection Diagnostic test
1 trials
Full Spectrum Microbiota Biological
1 trials
MoviPrep Drug
1 trials
Miralax Combination
1 trials
placebo vancomycin, Miralax, placebo intestinal microbiota Combination
1 trials

US sites by state

Facility locations filed on Gastro-Intestinal Disorder trials. A trial with sites in several states counts in each.

Arizona 4 trials
Massachusetts 2 trials
Texas 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
North Carolina 1 trials
Minnesota 1 trials
Kentucky 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gastro-Intestinal Disorder page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gastro-Intestinal Disorder condition card totals 8 registered trials; most-linked intervention Fuji Flim Processor VP-7000, Light Source BL-7000; top US site state Arizona. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.